IL136304A0 - Use of ginkgo extracts for preparing a medicine - Google Patents

Use of ginkgo extracts for preparing a medicine

Info

Publication number
IL136304A0
IL136304A0 IL13630498A IL13630498A IL136304A0 IL 136304 A0 IL136304 A0 IL 136304A0 IL 13630498 A IL13630498 A IL 13630498A IL 13630498 A IL13630498 A IL 13630498A IL 136304 A0 IL136304 A0 IL 136304A0
Authority
IL
Israel
Prior art keywords
preparing
medicine
ginkgo extracts
extracts
ginkgo
Prior art date
Application number
IL13630498A
Other languages
English (en)
Original Assignee
Sod Conseils Rech Applic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sod Conseils Rech Applic filed Critical Sod Conseils Rech Applic
Publication of IL136304A0 publication Critical patent/IL136304A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/16—Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Addiction (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Psychiatry (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Anesthesiology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Saccharide Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
IL13630498A 1997-12-03 1998-12-01 Use of ginkgo extracts for preparing a medicine IL136304A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9715230A FR2771639B1 (fr) 1997-12-03 1997-12-03 Utilisation d'extraits de ginkgo biloba pour preparer un medicament destine a faciliter le sevrage d'individus dependants de la consommation d'une substance engendrant une dependance et/ou une addiction
PCT/FR1998/002576 WO1999027943A1 (fr) 1997-12-03 1998-12-01 Utilisation d'extraits de ginkgo biloba pour preparer un medicament

Publications (1)

Publication Number Publication Date
IL136304A0 true IL136304A0 (en) 2001-05-20

Family

ID=9514108

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13630498A IL136304A0 (en) 1997-12-03 1998-12-01 Use of ginkgo extracts for preparing a medicine

Country Status (21)

Country Link
US (2) US6936285B1 (pl)
EP (1) EP1035858B1 (pl)
JP (1) JP2001524528A (pl)
KR (1) KR100597139B1 (pl)
CN (1) CN1188141C (pl)
AT (1) ATE216587T1 (pl)
AU (1) AU749752B2 (pl)
CA (1) CA2312856C (pl)
CZ (1) CZ299427B6 (pl)
DE (1) DE69805096T2 (pl)
DK (1) DK1035858T3 (pl)
ES (1) ES2177097T3 (pl)
FR (1) FR2771639B1 (pl)
HU (1) HUP0100223A3 (pl)
IL (1) IL136304A0 (pl)
NO (1) NO323707B1 (pl)
NZ (1) NZ505516A (pl)
PL (1) PL190849B1 (pl)
PT (1) PT1035858E (pl)
RU (1) RU2207140C2 (pl)
WO (1) WO1999027943A1 (pl)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2827518B1 (fr) * 2001-07-17 2005-07-08 Sod Conseils Rech Applic Utilisation d'extraits de ginkgo biloba pour preparer un medicament destine a traiter la sarcopenie
KR20030080623A (ko) * 2002-04-09 2003-10-17 주식회사 바이오메딕스 금연을 돕는 조성물 및 제조방법
US7169704B2 (en) 2002-06-21 2007-01-30 Samsung Electronics Co., Ltd. Method of cleaning a surface of a water in connection with forming a barrier layer of a semiconductor device
US20080038198A1 (en) * 2004-01-05 2008-02-14 Mitsubishi Pharma Corporation Method Of Screening Molecule Associated With Psychiatric Disorder
WO2007050599A2 (en) * 2005-10-27 2007-05-03 The Brigham & Women's Hospital, Inc. Ginkgolides in the treatment and prevention of ovarian cancer
DE102005062417A1 (de) * 2005-12-27 2007-08-23 Korth, Ruth-Maria, Dr.med. Kompositionen mit spezifischen und unspezifischen Lipidantagonisten
US11039997B2 (en) 2005-12-27 2021-06-22 Ruth-Maria Korth Cosmetic, dermatic, protective compositions comprising phospholipids, lecithins with peptides and at least one acetylating compound
RU2406488C1 (ru) * 2009-04-20 2010-12-20 Учреждение Российской академии медицинских наук Научно-исследовательский институт фармакологии Сибирского отделения РАМН Нейропротекторное средство
US20120171282A1 (en) * 2009-07-28 2012-07-05 Velleja Research S.R.L. Ginkgo biloba extract with a standardised ginkgo flavone glycosides content deprived of the paf-antagonist terpenic fraction, and compositions containing it, for the prevention and treatment of circulatory, cognitive, geriatric and sensory disorders
CN101946784B (zh) * 2010-09-26 2013-04-03 云南省农业科学院生物技术与种质资源研究所 银杏内酯b在制备抗烟草花叶病毒药物中的应用
CN112089772B (zh) * 2020-09-15 2022-02-18 汉济生物科技（武汉）有限公司 一种药物组合物及其在制备戒毒药物中的应用
CN113144021B (zh) * 2021-05-21 2022-08-19 常州工业职业技术学院 一种戒毒用中药组合物

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8725871D0 (en) * 1987-11-04 1987-12-09 Scras Ginkgolide derivatives
DE3940091A1 (de) * 1989-12-04 1991-06-06 Schwabe Willmar Gmbh & Co Extrakt aus blaettern von ginkgo biloba, verfahren zu seiner herstellung und den extrakt enthaltende arzneimittel
DE3940092A1 (de) * 1989-12-04 1991-06-06 Schwabe Willmar Gmbh & Co Extrakt aus blaettern von ginkgo biloba, verfahren zu seiner herstellung und den extrakt enthaltende arzneimittel
DE3940094A1 (de) * 1989-12-04 1991-06-06 Montana Ltd Wirkstoffkonzentrate und neue wirkstoff-kombinationen aus blaettern von ginkgo biloba, ein verfahren zu ihrer herstellung und die wirkstoff-konzentrate bzw. die wirkstoff-kombinationen enthaltenden arzneimittel
DE4008046C2 (de) * 1990-03-14 1999-09-16 Irbit Research & Consulting Ag Verfahren zur Herstellung eines Formteils aus Melaminharzschaumstoff
JP2924099B2 (ja) * 1990-06-13 1999-07-26 茂 川瀬 経口節煙剤
EP0618797B1 (de) * 1991-12-23 2000-03-15 Dr. Willmar Schwabe GmbH & Co. Bilobalid enthaltende pharmazeutische zubereitungen zur behandlung von spannungs- und angstzuständen
JP3181356B2 (ja) * 1992-03-25 2001-07-03 ダイセル化学工業株式会社 中枢神経作用薬
DE4317868C2 (de) * 1993-05-28 1996-04-18 Arrowdean Ltd Neuartiges Anxiolytikum
JPH0753371A (ja) * 1993-08-11 1995-02-28 Daicel Chem Ind Ltd 抗痙攣薬
KR0136986B1 (ko) * 1993-12-31 1998-04-25 김준웅 신규 징코라이드 유도체와 이의 제조방법
AUPM835394A0 (en) * 1994-09-23 1994-10-13 King, Michael G. Dr. Method for controlling or eliminating the need to smoke tobacco, and for treating ailments which may lead to the said need
US5976548A (en) * 1994-11-08 1999-11-02 Viva America Marketing, Inc. Nutritional supplement composition and use
GB9508533D0 (en) * 1995-04-27 1995-06-14 Sod Conseils Rech Applic Flavonoid extract of ginkgo biloba as flavouring and/or texturing agent

Also Published As

Publication number Publication date
CN1280499A (zh) 2001-01-17
KR20010032716A (ko) 2001-04-25
FR2771639A1 (fr) 1999-06-04
NO20002775D0 (no) 2000-05-30
US6936285B1 (en) 2005-08-30
HUP0100223A2 (hu) 2001-10-28
NO20002775L (no) 2000-06-02
AU1438099A (en) 1999-06-16
KR100597139B1 (ko) 2006-07-06
WO1999027943A1 (fr) 1999-06-10
CA2312856C (fr) 2009-04-07
AU749752B2 (en) 2002-07-04
DE69805096D1 (de) 2002-05-29
JP2001524528A (ja) 2001-12-04
DE69805096T2 (de) 2002-11-14
ATE216587T1 (de) 2002-05-15
CZ299427B6 (cs) 2008-07-23
FR2771639B1 (fr) 2000-05-05
NO323707B1 (no) 2007-06-25
PT1035858E (pt) 2002-10-31
PL190849B1 (pl) 2006-02-28
NZ505516A (en) 2001-10-26
CA2312856A1 (fr) 1999-06-10
PL340794A1 (en) 2001-02-26
ES2177097T3 (es) 2002-12-01
EP1035858A1 (fr) 2000-09-20
RU2207140C2 (ru) 2003-06-27
CN1188141C (zh) 2005-02-09
EP1035858B1 (fr) 2002-04-24
HUP0100223A3 (en) 2004-05-28
DK1035858T3 (da) 2002-08-19
CZ20002007A3 (cs) 2000-11-15
US20040180105A1 (en) 2004-09-16

Similar Documents

Publication Publication Date Title
DE69811378D1 (de) Zusammensetzungen zur behandlung von nikotinabhängigkeit, enthaltend mecamylamin und bupropion
IL136304A0 (en) Use of ginkgo extracts for preparing a medicine
DE69607015D1 (de) Inhalationsvorrichtung zur genauen und reproduzierbaren, datierten abgabe von pulverförmigen arzneistoffen
BG104317A (en) Method for the treatment of capsules and dry, powder pharmaceutical forms
EP1036573A4 (en) DEVICE FOR ADMINISTERING A SUBSTANCE THROUGH THE SKIN OR A MUCUTINE
NO20010627D0 (no) Anvendelse av Gingko Biloba ekstrakter for fremstilling av et medikament for behandling av amyotrofisk lateral sclerose
ES2177324T3 (es) Preparaciones de insulina destinadas a la entrega pulmonar y que contiene mentol.
HUP9903353A3 (en) 7alpha-(methyl-amino-pentyl)-estratrienes, pharmaceutical preparations which contain said 7alpha-(5-methylaminopentyl) -estratrienes and use thereof for production of drugs
MY107420A (en) Transdermal system exhibiting graduated drug release and its use for the local or systemic administration of active substances.
MY120958A (en) Use of a flavonoid extract of ginkgo biloba leaves, and more specifically of a terpene-free extract, in the pharmaceutical and/or cosmetic domain and more particularly in the buccodental domain
DE69823226D1 (de) Pharmazeutische zusammmensetzung, enthaltend ticlopidin und ginkgo biloba extrakt
DE60007074D1 (de) Sulfatierte phosphatidylinositole, ihre herstellung und verwendung
PT825859E (pt) Uso de forscoline ou extractos que o contenham na producao de um medicamento para o tratamento da dependencia do alcool
ZA9711270B (en) Precursory forms and new analogues of camptothecin, the processes for their preparation, their medical application and the pharmaceutical substances that contain them.
UA28284A (uk) Природний лікувальний засіб (його варіанти)
DE69904948D1 (de) Arzneimittel zur manipulation der t-zell immunantwort
HUP9902469A3 (en) Use of ginkgo biloba extracts for the preparation of pharmaceutical compositions, and method of cosmetic treatment using a ginkgo biloba extract
GB0024326D0 (en) Composition containing a herbal medicinal substance and a pharmaceutical drug
Hammond Resolution in dissolution. The regulatory environment facing dissolution, and where you can get help
Cheung et al. Traditional Chinese Medicine: Asthma Case Example
UA39252A (uk) Спосіб одержання заспокійливого судиннорозширюючого препарату
SI0825859T1 (en) Use of forskolin or extracts containing it in the manufacture of a medicament for the treatment of alcohol addiction
UA43011A (uk) Лікувальний засіб "агмелгін"
UA32387A (uk) Спосіб оцінки індивідуальної ефективності антиаритмічного препарату у хворих з суправентрикулярними тахіаритміями на фоні додаткових шляхів проведення
WO2004052337A3 (de) Nasale pharmazeutische präparation enthaltend eine lipophile flüssige oder gasförmige wirksubstanz

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees